Clinical trial

Cohort of Patients With Covid19: Constitution of Blood Samples Collections With Clinical Characterization

Name
COVIGENET
Description
Biological collection (blood sample) associated with clinical data from Covid-19 patients
Trial arms
Trial start
2020-05-31
Estimated PCD
2023-05-31
Trial end
2023-05-31
Status
Terminated
Treatment
Biological test
Blood sample
Arms:
Collection of blood sample
Size
500
Primary endpoint
Phenotype/genotype correlation research modulating the severity of Covid-19 disease
Anytime in the period of 10 years
Eligibility criteria
Inclusion Criteria: * Diagnosis of COVID-19 confirmed on RT-PCR test or chest scanner * Any age * Membership in the general social security system * Inform consent signed by the patient or by legal representatives for minors Exclusion Criteria: * Refusal of the patient or one of the legal representatives
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Collection of blood samples in a cohort of Covid-19 patients', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 500, 'type': 'ACTUAL'}}
Updated at
2024-04-12

1 organization

1 product

1 indication

Indication
COVID-19